NIH R01 · 2024
Eliminating the Immunogenicity of AAV Vectored HIV Antibody Delivery
Project Summary / Abstract This proposal describes the framework of an R01 grant for Alejandro Balazs, PhD. Dr. Balazs is currently an assistant professor at Harvard Medical School working as a principal investigator at the Ragon Institute of MGH, MIT & Harvard. Dr. Balazs’ research is focused on engineering the immune system via gene transfer as a novel means of creating protection against HIV. Broadly neutralizing antibodies (bNAbs) against human immunodeficiency virus (HIV) show great promise in HIV prevention and therapy as they potently neutralize a significant breadth of globally circulating HIV strains. Two recent Phase I clinical studies have demonstrated the safety and potential…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.